EASTMAN CHEMICAL CO (EMN) Fundamental Analysis & Valuation

NYSE:EMN • US2774321002

Current stock price

71.2 USD
-1.3 (-1.79%)
At close:
71.2 USD
0 (0%)
After Hours:

This EMN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. EMN Profitability Analysis

1.1 Basic Checks

  • EMN had positive earnings in the past year.
  • In the past year EMN had a positive cash flow from operations.
  • In the past 5 years EMN has always been profitable.
  • EMN had a positive operating cash flow in each of the past 5 years.
EMN Yearly Net Income VS EBIT VS OCF VS FCFEMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • EMN has a better Return On Assets (3.19%) than 73.49% of its industry peers.
  • The Return On Equity of EMN (7.95%) is better than 75.90% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 6.13%, EMN is in the better half of the industry, outperforming 67.47% of the companies in the same industry.
  • EMN had an Average Return On Invested Capital over the past 3 years of 7.13%. This is in line with the industry average of 6.58%.
Industry RankSector Rank
ROA 3.19%
ROE 7.95%
ROIC 6.13%
ROA(3y)5.08%
ROA(5y)5.24%
ROE(3y)13.33%
ROE(5y)14.08%
ROIC(3y)7.13%
ROIC(5y)8.47%
EMN Yearly ROA, ROE, ROICEMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • EMN has a Profit Margin of 5.42%. This is in the better half of the industry: EMN outperforms 73.49% of its industry peers.
  • EMN's Profit Margin has been stable in the last couple of years.
  • EMN has a Operating Margin (10.56%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of EMN has declined.
  • Looking at the Gross Margin, with a value of 21.09%, EMN is doing worse than 61.45% of the companies in the same industry.
  • In the last couple of years the Gross Margin of EMN has declined.
Industry RankSector Rank
OM 10.56%
PM (TTM) 5.42%
GM 21.09%
OM growth 3Y-5.12%
OM growth 5Y-2.29%
PM growth 3Y-10.27%
PM growth 5Y-0.81%
GM growth 3Y1.45%
GM growth 5Y-1.98%
EMN Yearly Profit, Operating, Gross MarginsEMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

4

2. EMN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EMN is destroying value.
  • The number of shares outstanding for EMN has been reduced compared to 1 year ago.
  • The number of shares outstanding for EMN has been reduced compared to 5 years ago.
  • Compared to 1 year ago, EMN has an improved debt to assets ratio.
EMN Yearly Shares OutstandingEMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M
EMN Yearly Total Debt VS Total AssetsEMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • EMN has an Altman-Z score of 2.37. This is not the best score and indicates that EMN is in the grey zone with still only limited risk for bankruptcy at the moment.
  • EMN has a Altman-Z score of 2.37. This is in the better half of the industry: EMN outperforms 62.65% of its industry peers.
  • EMN has a debt to FCF ratio of 11.29. This is a negative value and a sign of low solvency as EMN would need 11.29 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 11.29, EMN perfoms like the industry average, outperforming 59.04% of the companies in the same industry.
  • EMN has a Debt/Equity ratio of 0.70. This is a neutral value indicating EMN is somewhat dependend on debt financing.
  • The Debt to Equity ratio of EMN (0.70) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 11.29
Altman-Z 2.37
ROIC/WACC0.54
WACC11.34%
EMN Yearly LT Debt VS Equity VS FCFEMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • EMN has a Current Ratio of 1.37. This is a normal value and indicates that EMN is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of EMN (1.37) is worse than 73.49% of its industry peers.
  • A Quick Ratio of 0.63 indicates that EMN may have some problems paying its short term obligations.
  • EMN has a Quick ratio of 0.63. This is amonst the worse of the industry: EMN underperforms 89.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.63
EMN Yearly Current Assets VS Current LiabilitesEMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

4

3. EMN Growth Analysis

3.1 Past

  • EMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.56%.
  • Measured over the past years, EMN shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.54% on average per year.
  • The Revenue has decreased by -6.71% in the past year.
  • The Revenue has been growing slightly by 0.65% on average over the past years.
EPS 1Y (TTM)-31.56%
EPS 3Y-11.65%
EPS 5Y-2.54%
EPS Q2Q%-59.89%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.13%
Revenue growth 5Y0.65%
Sales Q2Q%-12.12%

3.2 Future

  • Based on estimates for the next years, EMN will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.84% on average per year.
  • The Revenue is expected to grow by 1.77% on average over the next years.
EPS Next Y9.23%
EPS Next 2Y12.21%
EPS Next 3Y12.72%
EPS Next 5Y14.84%
Revenue Next Year0.44%
Revenue Next 2Y1.9%
Revenue Next 3Y2.39%
Revenue Next 5Y1.77%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EMN Yearly Revenue VS EstimatesEMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B 10B
EMN Yearly EPS VS EstimatesEMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

5

4. EMN Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.19, the valuation of EMN can be described as correct.
  • 83.13% of the companies in the same industry are more expensive than EMN, based on the Price/Earnings ratio.
  • EMN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.89.
  • A Price/Forward Earnings ratio of 12.07 indicates a correct valuation of EMN.
  • 80.72% of the companies in the same industry are more expensive than EMN, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 22.19. EMN is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 13.19
Fwd PE 12.07
EMN Price Earnings VS Forward Price EarningsEMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, EMN is valued a bit cheaper than 74.70% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of EMN indicates a somewhat cheap valuation: EMN is cheaper than 73.49% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.16
EV/EBITDA 8.59
EMN Per share dataEMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • EMN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • EMN's earnings are expected to grow with 12.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.43
PEG (5Y)N/A
EPS Next 2Y12.21%
EPS Next 3Y12.72%

8

5. EMN Dividend Analysis

5.1 Amount

  • EMN has a Yearly Dividend Yield of 4.63%, which is a nice return.
  • EMN's Dividend Yield is rather good when compared to the industry average which is at 2.04. EMN pays more dividend than 91.57% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, EMN pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.63%

5.2 History

  • The dividend of EMN has a limited annual growth rate of 4.78%.
  • EMN has paid a dividend for at least 10 years, which is a reliable track record.
  • EMN has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.78%
Div Incr Years15
Div Non Decr Years30
EMN Yearly Dividends per shareEMN Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 80.38% of the earnings are spent on dividend by EMN. This is not a sustainable payout ratio.
  • The dividend of EMN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP80.38%
EPS Next 2Y12.21%
EPS Next 3Y12.72%
EMN Yearly Income VS Free CF VS DividendEMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
EMN Dividend Payout.EMN Dividend Payout, showing the Payout Ratio.EMN Dividend Payout.PayoutRetained Earnings

EMN Fundamentals: All Metrics, Ratios and Statistics

EASTMAN CHEMICAL CO

NYSE:EMN (3/27/2026, 8:13:47 PM)

After market: 71.2 0 (0%)

71.2

-1.3 (-1.79%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)01-29
Earnings (Next)04-23
Inst Owners91.54%
Inst Owner Change-4.65%
Ins Owners0.84%
Ins Owner Change7.23%
Market Cap8.12B
Revenue(TTM)8.75B
Net Income(TTM)474.00M
Analysts76.36
Price Target78.6 (10.39%)
Short Float %4.56%
Short Ratio2.94
Dividend
Industry RankSector Rank
Dividend Yield 4.63%
Yearly Dividend3.33
Dividend Growth(5Y)4.78%
DP80.38%
Div Incr Years15
Div Non Decr Years30
Ex-Date03-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.02%
Min EPS beat(2)-3.04%
Max EPS beat(2)3.07%
EPS beat(4)1
Avg EPS beat(4)-2.08%
Min EPS beat(4)-8.32%
Max EPS beat(4)3.07%
EPS beat(8)5
Avg EPS beat(8)3.91%
EPS beat(12)9
Avg EPS beat(12)5.28%
EPS beat(16)11
Avg EPS beat(16)2.19%
Revenue beat(2)0
Avg Revenue beat(2)-3.37%
Min Revenue beat(2)-3.51%
Max Revenue beat(2)-3.24%
Revenue beat(4)0
Avg Revenue beat(4)-2.73%
Min Revenue beat(4)-3.51%
Max Revenue beat(4)-1.63%
Revenue beat(8)1
Avg Revenue beat(8)-1.44%
Revenue beat(12)1
Avg Revenue beat(12)-2.45%
Revenue beat(16)3
Avg Revenue beat(16)-1.36%
PT rev (1m)1.31%
PT rev (3m)5.1%
EPS NQ rev (1m)-0.65%
EPS NQ rev (3m)-11.52%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)-5.49%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)-0.49%
Valuation
Industry RankSector Rank
PE 13.19
Fwd PE 12.07
P/S 0.93
P/FCF 19.16
P/OCF 8.38
P/B 1.36
P/tB 6.13
EV/EBITDA 8.59
EPS(TTM)5.4
EY7.58%
EPS(NY)5.9
Fwd EY8.28%
FCF(TTM)3.72
FCFY5.22%
OCF(TTM)8.5
OCFY11.94%
SpS76.7
BVpS52.24
TBVpS11.62
PEG (NY)1.43
PEG (5Y)N/A
Graham Number79.67
Profitability
Industry RankSector Rank
ROA 3.19%
ROE 7.95%
ROCE 7.57%
ROIC 6.13%
ROICexc 6.43%
ROICexgc 10.69%
OM 10.56%
PM (TTM) 5.42%
GM 21.09%
FCFM 4.84%
ROA(3y)5.08%
ROA(5y)5.24%
ROE(3y)13.33%
ROE(5y)14.08%
ROIC(3y)7.13%
ROIC(5y)8.47%
ROICexc(3y)7.54%
ROICexc(5y)8.89%
ROICexgc(3y)12.66%
ROICexgc(5y)15.23%
ROCE(3y)8.8%
ROCE(5y)10.46%
ROICexgc growth 3Y-15.19%
ROICexgc growth 5Y-0.92%
ROICexc growth 3Y-12.8%
ROICexc growth 5Y1.35%
OM growth 3Y-5.12%
OM growth 5Y-2.29%
PM growth 3Y-10.27%
PM growth 5Y-0.81%
GM growth 3Y1.45%
GM growth 5Y-1.98%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 11.29
Debt/EBITDA 2.92
Cap/Depr 106.43%
Cap/Sales 6.24%
Interest Coverage 4.3
Cash Conversion 67.5%
Profit Quality 89.45%
Current Ratio 1.37
Quick Ratio 0.63
Altman-Z 2.37
F-Score5
WACC11.34%
ROIC/WACC0.54
Cap/Depr(3y)130.13%
Cap/Depr(5y)124.87%
Cap/Sales(3y)7.2%
Cap/Sales(5y)6.56%
Profit Quality(3y)75.52%
Profit Quality(5y)78.99%
High Growth Momentum
Growth
EPS 1Y (TTM)-31.56%
EPS 3Y-11.65%
EPS 5Y-2.54%
EPS Q2Q%-59.89%
EPS Next Y9.23%
EPS Next 2Y12.21%
EPS Next 3Y12.72%
EPS Next 5Y14.84%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y-6.13%
Revenue growth 5Y0.65%
Sales Q2Q%-12.12%
Revenue Next Year0.44%
Revenue Next 2Y1.9%
Revenue Next 3Y2.39%
Revenue Next 5Y1.77%
EBIT growth 1Y-31.04%
EBIT growth 3Y-10.93%
EBIT growth 5Y-1.66%
EBIT Next Year59.9%
EBIT Next 3Y23.02%
EBIT Next 5Y20.52%
FCF growth 1Y-38.37%
FCF growth 3Y6.5%
FCF growth 5Y-16.93%
OCF growth 1Y-24.63%
OCF growth 3Y-0.17%
OCF growth 5Y-7.79%

EASTMAN CHEMICAL CO / EMN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EASTMAN CHEMICAL CO?

ChartMill assigns a fundamental rating of 5 / 10 to EMN.


Can you provide the valuation status for EASTMAN CHEMICAL CO?

ChartMill assigns a valuation rating of 5 / 10 to EASTMAN CHEMICAL CO (EMN). This can be considered as Fairly Valued.


Can you provide the profitability details for EASTMAN CHEMICAL CO?

EASTMAN CHEMICAL CO (EMN) has a profitability rating of 5 / 10.


What is the expected EPS growth for EASTMAN CHEMICAL CO (EMN) stock?

The Earnings per Share (EPS) of EASTMAN CHEMICAL CO (EMN) is expected to grow by 9.23% in the next year.


How sustainable is the dividend of EASTMAN CHEMICAL CO (EMN) stock?

The dividend rating of EASTMAN CHEMICAL CO (EMN) is 8 / 10 and the dividend payout ratio is 80.38%.